Advertisement
Home »

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Mar 06, 2023

ABOUT THE CONTRIBUTORS

  • Penglei Wang

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Xuechao Jia

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Bingbing Lu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Han Huang

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Jialin Liu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Xuejiao Liu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Qiong Wu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Yamei Hu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Pan Li

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Huifang Wei

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Tingting Liu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Dengyun Zhao

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Lingwei Zhang

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Xueli Tian

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Yanan Jiang

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    Yan Qiao

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China.

    Wenna Nie

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Xinli Ma

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China.

    Ruihua Bai

    The Department of Pathology, Affiliated Cancer Hospital of Zhengzhou University, 450000, Zhengzhou, China.

    Cong Peng

    The Department of Dermatology, Xiangya Hospital, Central South University, 410078, Changsha, China.

    Zigang Dong

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China. dongzg@zzu.edu.cn.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China. dongzg@zzu.edu.cn.

    The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, 450000, Zhengzhou, China. dongzg@zzu.edu.cn.

    State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, 450000, Zhengzhou, China. dongzg@zzu.edu.cn.

    Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, China. dongzg@zzu.edu.cn.

    Kangdong Liu

    Department of Pathophysiology, Basic Medicine Research Center, School of Basic Medical Sciences, AMS, Zhengzhou University, 450000, Zhengzhou, China. kdliu@zzu.edu.cn.

    China-US (Henan) Hormel Cancer Institute, 450000, Zhengzhou, China. kdliu@zzu.edu.cn.

    The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, 450000, Zhengzhou, China. kdliu@zzu.edu.cn.

    State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, 450000, Zhengzhou, China. kdliu@zzu.edu.cn.

    Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, China. kdliu@zzu.edu.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement